Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
Infrastructure? No Offer Description The Translational Synthetic Biology group led by Dr. Marc Güell at Universitat Pompeu Fabra (UPF) – and its future spin-off Synflora – is seeking a part-time business developer
-
funded by the EU-ERC, ID no. 101088060, in accordance with article 23 bis of Law 14/2011 on science, technology and innovation. Funding body and principal investigator EU’s Horizon Europe programme
-
NLP experts at UPF. The work will also involve the development of libraries, acquisition and preparation of datasets for experimentation, and intrinsic (metric-based) evaluation of the technology
-
8 Oct 2025 Job Information Organisation/Company Integra Therapeutics Research Field Biological sciences » Biological engineering Researcher Profile Recognised Researcher (R2) Positions PhD Positions
-
Offer Description What: A full-time 4-year PhD contract to engineer synthetic gene circuits Where: University Pompeu Fabra, Barcelona, Spain When: Deadline: 26th Oct 2025 or until filled – Start
-
? No Offer Description What: A full-time postdoc contract of up to 3.5 years to engineer synthetic gene circuits Where: University Pompeu Fabra, Barcelona, Spain When: Deadline: 26th Oct 2025 or until
-
. In addition, the incumbent is the specialist for review for faculty sabbatical and DIP leaves. The incumbent liaisons for UPFS with others in UP to track faculty on other leaves. The incumbent works
-
), the Institute of Evolutionary Biology (IBE, CSIC-UPF), the Barcelona Institute of Global Health (ISGlobal), and the Barcelona branch of the European Molecular Biology Laboratory (EMBL), among others. The BBRC is
-
| Protein Design | Artificial Intelligence | Lung Therapy | Live therapeutic Our Research Engineering of a human lung bacteria for human lung therapy combining synthetic biology and protein design Who are we